Delox Air - Continuous air bio-decontamination compatible with human presence

Delox AIR aims to revolutionize airborne pathogen decontamination in occupied spaces using a safe, energy-efficient solution, targeting high-risk environments to enhance public health and safety.

Subsidie
€ 1.893.340
2024

Projectdetails

Introduction

We learned from the pandemic that air quality is essential for people’s health. Current technologies did not effectively manage infectious diseases propagated by aerosol suspensions of pathogens, leading to the need for social distancing and dramatically impacting the economy and people’s mental health.

Challenge

The challenge is not only cleaning the space but keeping people safe and free from microorganisms’ exposure without harming them with harsh chemicals.

Solution

Delox AIR solution will change the paradigm of bio-decontamination of airborne pathogens in occupied spaces, a disruptive factor in the market. Based on our proprietary dryVHP, Delox AIR can kill microorganisms in the air with 99.99% efficacy, ensuring 100% human safety and consuming up to 20% less energy than current systems.

Integration

Delox AIR can be readily integrated into any HVAC systems for continuous air purification.

Market Overview

Delox AIR is part of the air purification market. We are targeting the commercial applications that capture the largest market (≈70% in 2021), accounting for €15.0 B by 2030.

Target Settings

We will first target settings characterised by:

  1. High occupancy density
  2. Presence of vulnerable individuals
  3. Elevated risk of pathogen spread

These include nursing homes, hospitals, office spaces, and educational and governmental buildings.

Business Model

Our business model (B2B) is based on indirect sales through distributors already working in the sector that will easily reach HVAC consultants/contractors (customers) designing and delivering a turnkey HVAC system for the end-user.

Funding Request

We request EIC funding to complete the development of our system and validate it in three different types of closed environments. Our solution addresses the EIC Challenge of “Aerosol Decontamination for Pandemic Management,” satisfying the unmet need of facilitating social interaction and preventing disease spread.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.893.340
Totale projectbegroting€ 2.767.272

Tijdlijn

Startdatum1-7-2024
Einddatum31-12-2026
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • DELOX - INVESTIGACAO, PROCESSOS E EQUIPAMENTOS CIENTIFICOS, LDApenvoerder

Land(en)

Portugal

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

A new cardioprotective drug for acute treatment of myocardial infarction

ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.

€ 2.499.999
EIC Accelerator

Clear, scalable and scientific framework to measure terrestrial biodiversity

3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.

€ 2.252.714
EIC Accelerator

Novel and Scalable microbial products for REgenerative agriculture

N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.

€ 2.499.999
EIC Accelerator

Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security

Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.

€ 2.499.999

Vergelijkbare projecten uit andere regelingen

MIT Haalbaarheid

Luchtzuiverende armaturen

Het project richt zich op het ontwikkelen van een innovatieve lichtoplossing voor het verbeteren van luchtkwaliteit in drukke omgevingen, met focus op haalbaarheidsonderzoek voor implementatie.

€ 20.000
MIT Haalbaarheid

Optimalisatie van afvangstrendementen voor lucht-gedragen fijnstof en ziekteverwekkers

ENS Technology ontwikkelt een prototype van de 'Positieve Ionisatie Technologie' om de afvang van schadelijke luchtdeeltjes en micro-organismen te optimaliseren voor betere luchtkwaliteit en gezondheidsbescherming.

€ 20.000
MIT Haalbaarheid

Haalbaarheidsonderzoek nonVirair-Vent

Domaplasma BV onderzoekt de haalbaarheid van een modulaire luchtzuiveringsunit voor bestaande ventilatiesystemen om virussen en ziektekiemen effectief te bestrijden en de luchtkwaliteit te verbeteren.

€ 20.000
MIT Haalbaarheid

Biologisch organisme virusafbraak en O2 omzetting filtersysteem voor (niet)medische toepassing

Het project onderzoekt de haalbaarheid van een duurzaam organisch filtersysteem dat virusdeeltjes opneemt en schone lucht verspreidt, ter bevordering van gezondheid en vermindering van CO2-uitstoot.

€ 20.000